Search Results

You are looking at 1 - 10 of 762 items for :

  • thyroid cancer x
Clear All
Free access

Yuji Ikeda, Kazuma Kiyotani, Poh Yin Yew, Taigo Kato, Kenji Tamura, Kai Lee Yap, Sarah M Nielsen, Jessica L Mester, Charis Eng, Yusuke Nakamura and Raymon H Grogan

cancer. Specifically, individuals with a primary thyroid cancer have a high incidence of second primary cancers even after adjusting for surveillance bias. One study of a cohort of 39 002 research participants suggested that when compared to the general

Free access

Veronica Kalhori, Melissa Magnusson, Muhammad Yasir Asghar, Ilari Pulli and Kid Törnquist

. 2013 , Pyne & Pyne 2013 , Takabe & Spiegel 2014 ). The importance of sphingolipids in thyroid cancer has not been studied in great detail. We have shown that S1P is without an effect on the proliferation and invasion of normal thyroid cells but

Free access

Anna Angelousi, Krystallenia I Alexandraki, George Kyriakopoulos, Marina Tsoli, Dimitrios Thomas, Gregory Kaltsas and Ashley Grossman

and lung cancers (30–40%), renal and gastrointestinal malignancies (10–20%) (Lam & Lo 2002, Wansaicheong & Goh 2016) Thyroid 1.9–24% (most common primary cancer: lung cancer, breast cancer, and melanoma) (Chung et al . 2012, Saito et al

Free access

Marjory Alana Marcello, Lucas Leite Cunha, Fernando Assis Batista and Laura Sterian Ward

, endometrial cancer, colon cancer, esophageal adenocarcinoma, kidney cancer, liver cancer, pancreatic cancer, prostate cancer, thyroid cancers, leukemia, non-Hodgkin lymphoma, and myeloma are related to overweight and obesity with respect to development

Free access

Weijun Wei, Heather Hardin and Quan-Yong Luo

Introduction Thyroid cancer is the fifth most common cancer in women in the United States and is the most commonly diagnosed cancer before the age of 30 years among women in China ( Chen et al. 2016 ). Although thyroid cancer is generally

Free access

Carles Zafon, Joan Gil, Beatriz Pérez-González and Mireia Jordà

Introduction Thyroid cancer, the most prevalent endocrine malignancy, covers the full range of phenotypes from indolent to the worst forms of human cancer. It is categorized into differentiated thyroid cancer (DTC), poorly differentiated

Free access

M Xing

Introduction Thyroid cancer is the most common endocrine malignancy. It can be classified histologically into follicular epithelial cell-derived papillary thyroid cancer (PTC), follicular thyroid cancer (FTC), anaplastic thyroid

Free access

Zhenying Guo, Heather Hardin and Ricardo V Lloyd

Introduction Thyroid cancer is one of the most rapidly increasing malignancies in the USA ( Siegel et al . 2013 ). Although most well-differentiated thyroid cancers have a good prognosis, a small percentage of these tumors are associated with

Free access

Hao Fu, Lin Cheng, Yuchen Jin and Libo Chen

thyroid carcinoma. With globally rising incidence, thyroid carcinoma has attracted much more concern than before. In theory, thyrotoxicosis with suppressed TSH should lead to a lower incidence of thyroid cancer than that observed in euthyroid patients

Free access

Rengyun Liu and Mingzhao Xing

glioblastoma ( Killela et al . 2013 , Liu et al . 2013 a ) as well as thyroid cancer ( Liu et al . 2013 b ). There are two common recurrent TERT promoter mutations in human cancer that are located at two hotspots: chr5, 1,295,228 C>T (C228T) and 1